Pillstats
Rx only · Solution · Oral

Aripiprazole

Aripiprazole

8 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US8 NDCs
8 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)89013
US makers8 labelers
Packages9
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 5 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.130$0.259$0.389$0.518Dec 2025Apr 2026Jul 2026
$0.332
Latest avg · Jul 22, 2026
-26%
Since Dec 17, 2025
8
Active US suppliers
33%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

6.1K12K18K24K2025 Q12025 Q22025 Q32025 Q42026 Q1
20K
Rx · 2026 Q1
3.8M
Units dispensed
+2%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it8 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Lannett Company, Inc.unknown2SUPPLYING
Advagen Pharma Ltdunknown1SUPPLYING
Aurobindo Pharma Limitedunknown1SUPPLYING
Apotex Corp.unknown1SUPPLYING
Amneal Pharmaceuticals LLCunknown1SUPPLYING
Chartwell RX, LLCunknown1SUPPLYING
VistaPharm, LLCunknown1SUPPLYING
QUAGEN PHARMACEUTICALS LLCunknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.